Michelle Zaldana-Flynn, MD
Plastic Surgery · Los Angeles, CANPI 1801216148
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,279 of the $4,479 with a category attached, or 73.2%. 17 manufacturers reported payments, led by Evolution Surgical, Inc at 27.3% of the total. Reporting peaked in 2022 at $1,743 and has fallen 64.8% since, to $614 in 2025.
Across 39 payments — averaging $114.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evolution Surgical, Inc$1K
- AbbVie$463
- Polynovo North America LLC$416
- Integra Lifesciences Corporation$394
- Mentor Worldwide LLC$307
- Avita Medical Americas, LLC$219
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,27973%
- Education$1,20027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evolution Surgical, Inc | 2 | $1,224 |
| AbbVie | 5 | $463 |
| Polynovo North America LLC | 5 | $416 |
| Integra Lifesciences Corporation | 3 | $394 |
| Mentor Worldwide LLC | 9 | $307 |
| Avita Medical Americas, LLC | 2 | $219 |
| Sientra, Inc. | 2 | $190 |
| Innovation Technologies Inc | 2 | $158 |
| RTI Surgical, Inc | 1 | $156 |
| Kls-martin L.p. | 1 | $149 |
| Kerecis Limited | 1 | $147 |
| Next Science LLC | 1 | $143 |
| Motiva USA, LLC | 1 | $142 |
| KCI USA, Inc. | 1 | $141 |
| Stryker | 1 | $129 |
| Biocomposites Inc | 1 | $84 |
| BD | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$734
- Kerecis Omega3 SurgiClose$441
- NATRELLE SALINE-FILLED BREAST IMPLANTS$375
- INTEGRA DERMAL REGENERATION TEMPLATE$245
- PRIMATRIX$245
- RECELL$219
- Novosorb BTM$210
- CORTIVA ALLOGRAFT DERMIS$156
- SURGIMEND$149
- Kerecis Omega3 GraftGuide$147
- Kerecis Omega3 Marigen$147
- Xperience$143
- BlastX$143
- SurgX$143
- Irrisept$143
- Motiva Implant Matrix$142
- V.A.C. VERAFLO$141
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$134
- VARIAX$129
How this compares
$4,479 in reported general payments places this provider in the 65th percentile of 780 plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Los Angeles
- Jason RoostaeianLos Angeles$127K
- Sheila Nazarian MobinLos Angeles$68K
- Rahm NazeraliPalo Alto$1.5M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$836K
- Anne PeledSan Francisco$570K
- Salvatore PacellaSan Diego$517K
- Hani SbitanySan Francisco$510K
- John ApostolidesSan Diego$460K
- Garrett WirthNewport Beach$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.